[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f0oLsxpZPZDCzfkh7PUJDdEAOZqqj-Fca3YpSravMBrk":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":53,"rows":60},"University of Delaware",[4],125,false,26,1,10612,4,115,[14,17,19,22,24,26,28,30],{"name":15,"count":16},"Cardiovascular Risk Factor",6,{"name":18,"count":16},"Stroke",{"name":20,"count":21},"Parkinson Disease",5,{"name":23,"count":21},"Aging",{"name":25,"count":21},"Hypertension",{"name":27,"count":11},"Mild Cognitive Impairment",{"name":29,"count":11},"Blood Pressure",{"name":31,"count":11},"Physical Activity",[33,38,43,48],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT04255160","Impact of Estradiol on Endothelial Function in Peri-Menopausal Women","2026-09-01","Estradiol",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT06745466","Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women","2026-10-31","ganirelix acetate",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT06094816","Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study","2028-01-01","Furosemide",{"nctId":49,"briefTitle":50,"date":51,"intervention":52},"NCT07420218","Menopausal Hormones and Sympathetic Activation","2030-06-01","Estrogen",[54,55,56,57,58,59],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[61,85,108,130,151,176,202,227,253,279,307],{"intervention":37,"totalTrials":9,"cells":62},{"EARLY_PHASE1":63,"PHASE1":66,"PHASE2":68,"PHASE3":70,"PHASE4":72,"NA":83},{"trials":64,"activeCount":65},[],0,{"trials":67,"activeCount":65},[],{"trials":69,"activeCount":65},[],{"trials":71,"activeCount":65},[],{"trials":73,"activeCount":9,"soonestReadout":36},[74],{"nctId":34,"briefTitle":35,"status":75,"phases":76,"primaryCompletion":36,"completion":41,"start":77,"enrollment":78,"conditions":79,"interventions":82},"ACTIVE_NOT_RECRUITING",[58],"2020-10-01",80,[80,81,52],"Perimenopause","Vasodilation",[37],{"trials":84,"activeCount":65},[],{"intervention":47,"totalTrials":9,"cells":86},{"EARLY_PHASE1":87,"PHASE1":89,"PHASE2":91,"PHASE3":93,"PHASE4":95,"NA":106},{"trials":88,"activeCount":65},[],{"trials":90,"activeCount":65},[],{"trials":92,"activeCount":65},[],{"trials":94,"activeCount":65},[],{"trials":96,"activeCount":9,"soonestReadout":46},[97],{"nctId":44,"briefTitle":45,"status":98,"phases":99,"primaryCompletion":46,"completion":100,"start":101,"enrollment":102,"conditions":103,"interventions":105},"RECRUITING",[58],"2028-07-01","2024-03-05",120,[104],"Salt-Sensitivity of Blood Pressure",[47],{"trials":107,"activeCount":65},[],{"intervention":42,"totalTrials":9,"cells":109},{"EARLY_PHASE1":110,"PHASE1":112,"PHASE2":114,"PHASE3":116,"PHASE4":118,"NA":128},{"trials":111,"activeCount":65},[],{"trials":113,"activeCount":65},[],{"trials":115,"activeCount":65},[],{"trials":117,"activeCount":65},[],{"trials":119,"activeCount":9,"soonestReadout":41},[120],{"nctId":39,"briefTitle":40,"status":98,"phases":121,"primaryCompletion":41,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":127},[58],"2027-10","2024-11-15",30,[52,126],"Premenopause",[42],{"trials":129,"activeCount":65},[],{"intervention":52,"totalTrials":9,"cells":131},{"EARLY_PHASE1":132,"PHASE1":134,"PHASE2":136,"PHASE3":138,"PHASE4":140,"NA":149},{"trials":133,"activeCount":65},[],{"trials":135,"activeCount":65},[],{"trials":137,"activeCount":65},[],{"trials":139,"activeCount":65},[],{"trials":141,"activeCount":9,"soonestReadout":51},[142],{"nctId":49,"briefTitle":50,"status":143,"phases":144,"primaryCompletion":51,"completion":145,"start":36,"enrollment":78,"conditions":146,"interventions":148},"NOT_YET_RECRUITING",[58],"2030-12-31",[147],"Perimenopausal Women",[52],{"trials":150,"activeCount":65},[],{"intervention":152,"totalTrials":9,"cells":153},"celecoxib",{"EARLY_PHASE1":154,"PHASE1":156,"PHASE2":158,"PHASE3":160,"PHASE4":162,"NA":174},{"trials":155,"activeCount":65},[],{"trials":157,"activeCount":65},[],{"trials":159,"activeCount":65},[],{"trials":161,"activeCount":65},[],{"trials":163,"activeCount":65},[164],{"nctId":165,"briefTitle":166,"status":167,"phases":168,"primaryCompletion":169,"completion":169,"start":170,"enrollment":171,"conditions":172,"interventions":173},"NCT00624559","The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure","COMPLETED",[58],"2009-01","2008-02",12,[25],[152],{"trials":175,"activeCount":65},[],{"intervention":177,"totalTrials":9,"cells":178},"Hypertensives",{"EARLY_PHASE1":179,"PHASE1":181,"PHASE2":183,"PHASE3":185,"PHASE4":187,"NA":200},{"trials":180,"activeCount":65},[],{"trials":182,"activeCount":65},[],{"trials":184,"activeCount":65},[],{"trials":186,"activeCount":65},[],{"trials":188,"activeCount":65},[189],{"nctId":190,"briefTitle":191,"status":192,"phases":193,"primaryCompletion":194,"completion":194,"start":195,"enrollment":196,"conditions":197,"interventions":199},"NCT03371823","Vascular Dysfunction in Hypertensive Postmenopausal Women","TERMINATED",[58],"2019-12-31","2017-09-01",8,[198,25],"Cardiovascular Diseases",[177],{"trials":201,"activeCount":65},[],{"intervention":203,"totalTrials":9,"cells":204},"Niagen®",{"EARLY_PHASE1":205,"PHASE1":207,"PHASE2":209,"PHASE3":221,"PHASE4":223,"NA":225},{"trials":206,"activeCount":65},[],{"trials":208,"activeCount":65},[],{"trials":210,"activeCount":65},[211],{"nctId":212,"briefTitle":213,"status":167,"phases":214,"primaryCompletion":215,"completion":216,"start":217,"enrollment":218,"conditions":219,"interventions":220},"NCT03482167","NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment",[55,56],"2024-01-08","2024-01-22","2019-03-20",64,[27],[203],{"trials":222,"activeCount":65},[],{"trials":224,"activeCount":65},[],{"trials":226,"activeCount":65},[],{"intervention":228,"totalTrials":9,"cells":229},"Botox",{"EARLY_PHASE1":230,"PHASE1":232,"PHASE2":234,"PHASE3":236,"PHASE4":238,"NA":240},{"trials":231,"activeCount":65},[],{"trials":233,"activeCount":65},[],{"trials":235,"activeCount":65},[],{"trials":237,"activeCount":65},[],{"trials":239,"activeCount":65},[],{"trials":241,"activeCount":65},[242],{"nctId":243,"briefTitle":244,"status":167,"phases":245,"primaryCompletion":246,"completion":246,"start":247,"enrollment":248,"conditions":249,"interventions":252},"NCT01803464","Effect of Botox and Vibration on Bone in Children With Cerebral Palsy",[59],"2015-02","2012-03",29,[250,251],"Cerebral Palsy","Muscle Spasticity",[228],{"intervention":254,"totalTrials":9,"cells":255},"treatment",{"EARLY_PHASE1":256,"PHASE1":258,"PHASE2":260,"PHASE3":262,"PHASE4":264,"NA":266},{"trials":257,"activeCount":65},[],{"trials":259,"activeCount":65},[],{"trials":261,"activeCount":65},[],{"trials":263,"activeCount":65},[],{"trials":265,"activeCount":65},[],{"trials":267,"activeCount":65},[268],{"nctId":269,"briefTitle":270,"status":167,"phases":271,"primaryCompletion":272,"completion":273,"start":274,"enrollment":275,"conditions":276,"interventions":278},"NCT00843453","Long-term Use of Proton Pump Inhibitors May Cause Vitamin B12 Deficiency in the Institutionalized Elderly",[59],"2008-01","2008-04","2006-11",36,[277],"Vitamin B12 Deficiency",[254],{"intervention":280,"totalTrials":9,"cells":281},"MitoTempol",{"EARLY_PHASE1":282,"PHASE1":284,"PHASE2":286,"PHASE3":288,"PHASE4":290,"NA":292},{"trials":283,"activeCount":65},[],{"trials":285,"activeCount":65},[],{"trials":287,"activeCount":65},[],{"trials":289,"activeCount":65},[],{"trials":291,"activeCount":65},[],{"trials":293,"activeCount":65},[294],{"nctId":295,"briefTitle":296,"status":167,"phases":297,"primaryCompletion":298,"completion":299,"start":300,"enrollment":301,"conditions":302,"interventions":305},"NCT06466655","Daily Stress and Vascular Function in Midlife as a Risk Factor for Cognitive Decline",[59],"2025-04-10","2025-05-29","2024-05-30",17,[303,304],"Middle-aged Adults","Major Depressive Disorder",[280,306],"Lactated Ringer's",{"intervention":306,"totalTrials":9,"cells":308},{"EARLY_PHASE1":309,"PHASE1":311,"PHASE2":313,"PHASE3":315,"PHASE4":317,"NA":319},{"trials":310,"activeCount":65},[],{"trials":312,"activeCount":65},[],{"trials":314,"activeCount":65},[],{"trials":316,"activeCount":65},[],{"trials":318,"activeCount":65},[],{"trials":320,"activeCount":65},[321],{"nctId":295,"briefTitle":296,"status":167,"phases":322,"primaryCompletion":298,"completion":299,"start":300,"enrollment":301,"conditions":323,"interventions":324},[59],[303,304],[280,306]]